SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C - Offering Statement:
SEC Accession No. 0001670254-21-001351
Filing Date
2021-12-06
Accepted
2021-12-03 20:14:10
Documents
18

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 12288
2 document_1.pdf EX-99 7671646
3 document_2.pdf EX-99 1871382
4 document_3.pdf EX-99 122562
5 document_4.pdf EX-99 19344774
6 document_5.pdf EX-99 9253790
7 document_6.pdf EX-99 19344773
8 document_7.pdf EX-99 9253794
9 document_8.pdf EX-99 3185521
10 document_9.pdf EX-99 461089
11 document_10.pdf EX-99 208663
12 document_11.pdf EX-99 282409
13 document_12.pdf EX-99 542336
14 document_13.pdf EX-99 1032362
15 document_14.pdf EX-99 253260
16 document_15.pdf EX-99 15043667
17 document_16.pdf EX-99 28617907
18 documents_list.htm EX-99 123
  Complete submission text file 0001670254-21-001351.txt   158174701
Mailing Address PO BOX 24752 MINNEAPOLIS MN 55424
Business Address PO BOX 24752 MINNEAPOLIS MN 55424 5106982462
TTC Oncology, LLC (Filer) CIK: 0001889745 (see all company filings)

IRS No.: 474783726
Type: C | Act: 33 | File No.: 020-29310 | Film No.: 211471664